Eagle Meds Services
Darzalex Faspro (Daratumumab and Hyaluronidase-Fihj (human Recombinant))
Available to SourceHuman Prescription Drug
NDC 57894-0503-01

Darzalex Faspro (Daratumumab and Hyaluronidase-Fihj (human Recombinant))

Package · 1 VIAL, SINGLE-DOSE in 1 BOX (57894-503-01) / 15 mL in 1 VIAL, SINGLE-DOSE

Active ingredients · Daratumumab, Hyaluronidase (human Recombinant)

1800 mg/15mL / 30000 U/15mL · Injection
By Janssen Biotech, Inc.

Daratumumab and Hyaluronidase-Fihj (human Recombinant) · Injection · 1800 mg/15mL / 30000 U/15mL · Subcutaneous

NDC
57894-0503-01
Route
Subcutaneous
Therapeutic class
Antibodies, Monoclonal [CS], CD38-directed Antibody Interactions [MoA], CD38-directed Cytolytic Antibody , Endoglycosidase , Glycoside Hydrolases [CS]
Marketing category
BLA
Request This Medication

*Expect a reply within 2 business hours with availability and pricing.

Additional information

Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.

Request a Quote

Request this medication.

Tell us the quantity you need and we’ll respond with availability, lot details, dating, and pricing within 2 business hours. Mark it as Rush or Emergency if you need it faster.

  • DSCSA-compliant pedigree on every order
  • Cold-chain capable where applicable
  • Same-day fulfillment available for urgent needs
Requesting
Darzalex Faspro (Daratumumab and Hyaluronidase-Fihj (human Recombinant))
NDC 57894-0503-01